He Jiankui spent three years in prison after creating gene-edited babies. Now back at work, he sees a greater opening for ...

The enormous ocean-to-lake compound, which is owned by biotech billionaire Randal J. Kirk, first hit the market for $134 ...

The biology-first hair care brand has brought the hair stylist and forecaster on as Global Brand Ambassador as it sets out to ...

Rare Pediatric Disease Priority Review Voucher (PRV) granted by FDA at approval to be transferred from Sentynl Therapeutics to Cyprium Cyprium eligible to receive tiered royalties and up to $129 milli ...

Leading event to bridge research, clinical adoption, and investment in microbiome-enabled health hosted by CE-Ventures, the ...

Pasithea Therapeutics Corp. (NASDAQ: KTTA) ("Pasithea" or the "Company"), a clinical-stage biotechnology company developing PAS-004, a next-generation oral macrocyclic ...

XTL will acquire NeuroNOS for 19.9% of its issued share capital, $1 million in cash, and milestone-based contingent payments totaling up to $32.5 million. ・NeuroNOS is a biotechnology company eyeing ...

In his inaugural J.P. Morgan Healthcare Conference speech, newly minted Dexcom CEO Jake Leach looked to ease concerns over ...

Tulane’s Freeman School hosts health leaders Jan. 22 to explore AI, diagnostics, and medical device innovation in health care ...

After a flurry of Big Pharma deals in the first week of the new year, the life sciences industry is heading to San Francisco ...

Once-touted 11th Avenue biotech corridor faces reset as Hudson Research Center is recapitalized amid slower life sciences ...

YDES YD Bio (NASDAQ:YDES) is an integrated biotechnology company that combines diagnostics, precision medicine, and ...